Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Kariminejad - |
RCV001814340 | SCV001755127 | pathogenic | Abnormality of the musculature | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002568237 | SCV002959572 | pathogenic | LAMA2-related muscular dystrophy | 2023-08-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1180611). This sequence change creates a premature translational stop signal (p.Arg84*) in the LAMA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA2 are known to be pathogenic (PMID: 18700894, 32904964). This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with LAMA2-related conditions (PMID: 32154989). |
Baylor Genetics | RCV003470856 | SCV004190521 | pathogenic | Merosin deficient congenital muscular dystrophy | 2023-04-05 | criteria provided, single submitter | clinical testing |